Company Filing History:
Years Active: 2003-2006
Title: Lianli Li: Innovator in Transnasal Anticonvulsive Compositions
Introduction
Lianli Li is a notable inventor based in Fresh Meadows, NY (US). He has made significant contributions to the field of pharmaceutical compositions, particularly in the area of anticonvulsive agents. With a total of 2 patents, his work focuses on innovative methods of drug administration.
Latest Patents
Lianli Li's latest patents include groundbreaking inventions related to transnasal anticonvulsive compositions. One of his patents discloses a novel method of vehicle modulated administration of an anticonvulsive agent to the mucous membranes of humans and animals. The vehicle system consists of an aqueous pharmaceutical carrier that includes an aliphatic alcohol (10–80%) or a glycol (10–80%), along with combinations of a biological surfactant such as a bile salt or lecithin. This pharmaceutical composition allows for controlled and enhanced transmucosal permeation and absorption of medicaments through both single and multiple administrations. Notably, nasal administration of this preparation achieves a high plasma concentration of the anticonvulsant almost as rapidly as intravenous administration. Such compositions are particularly beneficial for the prompt treatment of patients experiencing status epilepticus and other fever-induced seizures.
Career Highlights
Lianli Li is currently associated with Sk Corporation, where he continues to develop innovative pharmaceutical solutions. His work has garnered attention for its potential to improve patient outcomes in emergency medical situations.
Collaborations
Lianli Li collaborates with esteemed colleagues, including Yong Moon Choi and Kwon H Kim, who contribute to his research and development efforts.
Conclusion
Lianli Li's contributions to the field of pharmaceuticals, particularly in the development of transnasal anticonvulsive compositions, highlight his innovative spirit and dedication to improving medical treatments. His work is poised to make a significant impact on emergency care for patients with seizure disorders.